Turning Point Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Turning Point Therapeutics, Inc.
CIK #0001595893
EDGAR Form CIK 2011 - 2025
10-K [0001595893]
10-Q [0001595893]
3 [0001595893]
4 [0001595893]
8-K [0001595893]
D [0001595893]
SC 13D [0001595893]
SC 13G [0001595893]
Form 13D/13G Filer Form 13D/13G Subject Filed
Cormorant Asset Management LP Turning Point Therapeutics Inc [2022-02-14]
Wellington Management Group LLP Turning Point Therapeutics Inc [2022-02-04]
Price T Rowe Associates Inc /MD/ Turning Point Therapeutics Inc [2021-02-16]
Vanguard Group Inc Turning Point Therapeutics Inc [2020-02-11]
BlackRock Inc Turning Point Therapeutics Inc [2020-02-07]
CUI Jingrong Jean Turning Point Therapeutics Inc [2020-02-05]
FMR LLC Turning Point Therapeutics Inc [2019-08-12]
Foresite Capital Fund IV LP Turning Point Therapeutics Inc [2019-05-02]
GlaxoSmithKline PLC Turning Point Therapeutics Inc [2019-04-26]
Cormorant Asset Management LP Turning Point Therapeutics Inc [2019-04-25]
View All
Form 3/4/5 Subject 2011 - 2025
Turning Point Therapeutics, Inc.
Countouriotis Athena
Nicholson Garry A
Machado Patrick
George Simeon
Gallagher Carol Giltner
Bodem Barbara W.
Alles Mark J
Tombesi Paolo
Sun Brian
View All
Terms | Privacy | Guide
tony@aum13f.com